314 related articles for article (PubMed ID: 11167878)
1. Influence of aspirin on early allograft thrombosis and chronic allograft nephropathy following renal transplantation.
Murphy GJ; Taha R; Windmill DC; Metcalfe M; Nicholson ML
Br J Surg; 2001 Feb; 88(2):261-6. PubMed ID: 11167878
[TBL] [Abstract][Full Text] [Related]
2. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
3. Outcome after kidney transplantation in children with thrombotic risk factors.
Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
[TBL] [Abstract][Full Text] [Related]
4. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
He X; Johnston A
Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis.
Murphy GJ; Waller JR; Sandford RS; Furness PN; Nicholson ML
Br J Surg; 2003 Jun; 90(6):680-6. PubMed ID: 12808614
[TBL] [Abstract][Full Text] [Related]
6. The natural history of chronic allograft nephropathy.
Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
[TBL] [Abstract][Full Text] [Related]
7. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
8. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
9. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study.
Gutiérrez P; Marrero D; Hernández D; Vivancos S; Pérez-Tamajón L; Rodríguez de Vera JM; Alarcó A; González-Posada JM
Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283
[TBL] [Abstract][Full Text] [Related]
10. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
Jevnikar A; Arlen D; Barrett B; Boucher A; Cardella C; Cockfield SM; Rush D; Paraskevas S; Shapiro J; Shoker A; Yilmaz S; Zaltzman JS; Kiberd B
Transplantation; 2008 Oct; 86(7):953-60. PubMed ID: 18852662
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
Stevens RB; Mercer DF; Grant WJ; Freifeld AG; Lane JT; Groggel GC; Rigley TH; Nielsen KJ; Henning ME; Skorupa JY; Skorupa AJ; Christensen KA; Sandoz JP; Kellogg AM; Langnas AN; Wrenshall LE
Transplantation; 2008 May; 85(10):1391-9. PubMed ID: 18497677
[TBL] [Abstract][Full Text] [Related]
12. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
13. Comparison of renal allograft fibrosis after transplantation from heart-beating and non-heart-beating donors.
Bains JC; Sandford RM; Brook NR; Hosgood SA; Lewis GR; Nicholson ML
Br J Surg; 2005 Jan; 92(1):113-8. PubMed ID: 15593295
[TBL] [Abstract][Full Text] [Related]
14. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
15. Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques.
Yehia M; Matheson PJ; Merrilees MJ; Beaumont BW; Pilmore HL
Nephrology (Carlton); 2006 Jun; 11(3):261-6. PubMed ID: 16756643
[TBL] [Abstract][Full Text] [Related]
16. A single-center study of the technical aspects and outcome of third and subsequent renal transplants.
Hagan C; Hickey DP; Little DM
Transplantation; 2003 May; 75(10):1687-91. PubMed ID: 12777857
[TBL] [Abstract][Full Text] [Related]
17. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676
[TBL] [Abstract][Full Text] [Related]
18. Favorable outcome of renal transplantation in patients with IgA nephropathy.
Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
[TBL] [Abstract][Full Text] [Related]
20. Primary renal graft thrombosis.
Bakir N; Sluiter WJ; Ploeg RJ; van Son WJ; Tegzess AM
Nephrol Dial Transplant; 1996 Jan; 11(1):140-7. PubMed ID: 8649623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
